Literature DB >> 15506819

Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects.

Satu-Maarit Heinonen1, Kristiina Wähälä, Herman Adlercreutz.   

Abstract

Dietary supplements manufactured from red clover are widely marketed to provide the beneficial health effects of isoflavones without changing the original diet. In this study the metabolism of formononetin and biochanin A, the principal isoflavones of red clover, was studied in human subjects. Seven women ingested four red clover dietary supplements, and the metabolites of the isoflavones were identified in their urine samples. The structures of trimethylsilyl derivatives of the metabolites were established by GC-MS. New reduced metabolites of formononetin (dihydroformononetin and angolensin) and biochanin A (dihydrobiochanin A and 6'-hydroxyangolensin) were identified in urine samples using authentic reference compounds. Possible metabolic pathways are presented for the red clover isoflavones formononetin and biochanin A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506819     DOI: 10.1021/jf0492767

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  19 in total

Review 1.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

2.  The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract.

Authors:  Nancy L Booth; Cassia R Overk; Ping Yao; Joanna E Burdette; Dejan Nikolic; Shao-Nong Chen; Judy L Bolton; Richard B van Breemen; Guido F Pauli; Norman R Farnsworth
Journal:  J Altern Complement Med       Date:  2006-03       Impact factor: 2.579

3.  Chemoprevention of mammary tumorigenesis and chemomodulation of the antioxidative enzymes and peroxidative damage in prepubertal Sprague Dawley rats by Biochanin A.

Authors:  Prachi Mishra; R K Kale; Anand Kar
Journal:  Mol Cell Biochem       Date:  2008-02-14       Impact factor: 3.396

Review 4.  Role of the normal gut microbiota.

Authors:  Sai Manasa Jandhyala; Rupjyoti Talukdar; Chivkula Subramanyam; Harish Vuyyuru; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

5.  Seasonal variation of red clover (Trifolium pratense L., Fabaceae) isoflavones and estrogenic activity.

Authors:  Nancy L Booth; Cassia R Overk; Ping Yao; Steve Totura; Yunfan Deng; A S Hedayat; Judy L Bolton; Guido F Pauli; Norman R Farnsworth
Journal:  J Agric Food Chem       Date:  2006-02-22       Impact factor: 5.279

6.  Absorptive constituents and their metabolites in drug-containing urine samples from Wuzhishan miniature pigs orally administered with Buyang Huanwu decoction.

Authors:  Dong-Hui Yang; Xiang-Liang Ren; Feng Xu; Xiao-Qing Ma; Guang-Xue Liu; Cang-Hai Li; Chen Li; Shao-Qing Cai
Journal:  J Nat Med       Date:  2013-03-21       Impact factor: 2.343

7.  Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.

Authors:  Emily Powell; Erin Shanle; Ashley Brinkman; Jun Li; Sunduz Keles; Kari B Wisinski; Wei Huang; Wei Xu
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 8.  Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties.

Authors:  Laura Marín; Elisa M Miguélez; Claudio J Villar; Felipe Lombó
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

Review 9.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

10.  The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.

Authors:  Sofia Bellou; Evdoxia Karali; Eleni Bagli; Nawaf Al-Maharik; Lucia Morbidelli; Marina Ziche; Herman Adlercreutz; Carol Murphy; Theodore Fotsis
Journal:  Mol Cancer       Date:  2012-05-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.